Document Detail

Should We Look for Celiac Disease among all Patients with Liver Function Test Abnormalities?
MedLine Citation:
PMID:  22448309     Owner:  NLM     Status:  PubMed-not-MEDLINE    
BACKGROUND: Celiac disease (CD) has been found in up to 10% of the patients presenting with unexplained abnormal liver function tests (LFT). As there is no precise data from our country in this regard, we investigated the prevalence of CD in patients presenting with abnormal LFT.
METHODS: From 2003 to 2008, we measured IgA anti-tissue transglutaminase (t-TG) antibody (with ELISA technique) within the first-level screening steps for all patients presenting with abnormal LFT to three outpatient gastroenterology clinics in Isfahan, IRAN. All subjects with an IgA anti-tTG antibody value of >10 μ/ml (seropositive) were undergone upper gastrointestinal endoscopy and duodenal biopsy. Histopathological changes were assessed according to the Marsh classification. CD was defined as being seropositive with Marsh I or above in histopathology and having a good response to gluten free diet (GFD).
RESULTS: During the study, 224 patients were evaluated, out of which, 10 patients (4.4%) were seropositive for CD. Duodenal biopsies were performed in eight patients and revealed six (2.7%) cases of Marsh I or above (four Marsh IIIA, two Marsh I), all of them had good response to GFD. The overall prevalence of CD among patients with hypertransaminasemia, autoimmune hepatitis, and cryptogenic cirrhosis was determined as 10.7% (3/28), 3.4% (2/59), and 5.3% (1/19), respectively.
CONCLUSION: Serological screening with IgA anti-tTG antibody test should be routinely performed in patients presenting with abnormal LFT and especially those with chronic liver diseases including hypertransaminasemia, autoimmune hepatitis, and cryptogenic cirrhosis.
Mohammad Hassan Emami; Marzieh Hashemi; Soheila Kouhestani; Hajar Taheri; Somayeh Karimi
Related Documents :
18591009 - Fluctuations in tremor and respiration in patients with parkinson's disease.
8058159 - Beta 2-adrenergic agonist as adjunct therapy to levodopa in parkinson's disease.
19117359 - Walking along circular trajectories in parkinson's disease.
19412479 - Patterns of prefrontal dysfunction in alcoholics with and without korsakoff's syndrome,...
17986529 - Factors that might adversely affect short-term survival of patients starting peritoneal...
17855149 - [(11)c]-pib imaging in patients with parkinson's disease: preliminary results.
9365749 - Local reactions after injection of iodinated contrast material: detection, management, ...
12119079 - Functional outcome: a case for mild traumatic brain injury.
10211629 - Cardiac troponin elevations in chronic renal failure: prevalence and clinical significa...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of preventive medicine     Volume:  3     ISSN:  2008-8213     ISO Abbreviation:  Int J Prev Med     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-26     Completed Date:  2012-10-02     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101535380     Medline TA:  Int J Prev Med     Country:  Iran    
Other Details:
Languages:  eng     Pagination:  167-72     Citation Subset:  -    
Department of Gastroenterology and Hepatology, Isfahan University of Medical Sciences, Isfahan, Iran.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  LDL Particle Size and Reactive Oxygen Metabolites in Dyslipidemic Patients.
Next Document:  Establishment of Health Clinics as Mass Screening and Referral Systems for Chronic Non-communicable ...